» Authors » Vijayanarayana Kunhikatta

Vijayanarayana Kunhikatta

Explore the profile of Vijayanarayana Kunhikatta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 103
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Al Shakhori M, Arain S, Abdulsalim S, Salim Karattuthodi M, Al Dhamen M, Almutairi S, et al.
J Pharm Policy Pract . 2025 Feb; 18(1):2460038. PMID: 39931673
Background: The study aimed to evaluate the effectiveness of telepsychiatry combined with the expertise of psychiatric clinical pharmacists in identifying and addressing drug-related problems (DRPs) associated with psychotropic medications. Additionally,...
2.
Rashid M, Nair S, Poojari P, Belle V, Kunhikatta V, Vaz D, et al.
Heliyon . 2025 Feb; 11(3):e42146. PMID: 39916845
Objective: Diverse inflammatory pathology is involved in acute respiratory distress syndrome (ARDS). This study aimed to assess the role of complement component fragment 5a (C5a) receptor 2 (C5aR2) in prognosis...
3.
Patil P, Desai M, Baburaj G, Rao M, Kunhikatta V, Udupa K, et al.
J Oncol Pharm Pract . 2025 Jan; 10781552251314811. PMID: 39846287
Introduction: The utilization of CDK4/6 inhibitors has led to compromised survival rates for breast cancer patients. Consequently, certain treatment aspects, involving adherence and drug-to-drug interactions, are gaining prominence. To develop...
4.
Somasundaram M, Mathew S, Paul S, Kurian S, Kunhikatta V, Karanth S, et al.
Ann Med . 2024 Nov; 56(1):2425829. PMID: 39520151
Background: Evidence shows that diabetes raises the probability of contracting COVID-19 and associated complications. We hypothesize that metformin, being pleiotropic, may improve COVID-19 in diabetics. Methods: A retrospective cohort study...
5.
Badanthadka M, Dsouza V, Shetty M, Augustin V, Rathnakar Jalajakshi M, Bangera Sheshappa M, et al.
Turk J Pharm Sci . 2024 Jul; 21(3):184-191. PMID: 38994804
Objectives: Literature suggests that a high-fat diet (HFD) potentially increases the risk of chemical/drug-induced toxicity after an acute overdose. Drug/chemical-induced hepatotoxicity has been well studied, and the mechanism that regulates...
6.
Kaur H, Chandran V, Rashid M, Kunhikatta V, Poojari P, Bakkannavar S, et al.
J Forensic Leg Med . 2023 Jun; 97:102548. PMID: 37327568
The Acute Physiology and Chronic Health Evaluation II (APACHE II) scoring system is utilised as a prognostic method in paraquat poisoning; however, current evidence shows ambiguity. Although some studies have...
7.
Rashid M, Ramakrishnan M, Muthu D, Chandran V, Thunga G, Kunhikatta V, et al.
Clin Epidemiol Glob Health . 2023 Jun; 13:100972. PMID: 37309426
Purpose: The clinical profile and factors affecting outcomes in acute respiratory distress syndrome (ARDS) from adequately sample-sized Indian studies are still lacking. We aimed to investigate the clinical profile, treatment...
8.
Sanghvi K, Subraya C, Pai V, Nanjundaiah A, Kunhikatta V
Curr Drug Saf . 2023 Mar; 18(2):138-142. PMID: 36883268
There is a growing awareness of a disease at many levels, its treatment, and treatment outcomes including side effects. Alternative therapy techniques, herbal medicines and formulations are extensively acknowledged and...
9.
Karimi F, Lewis L, Thunga G, Najmi A, Sahu P, Kunhikatta V
Med Pharm Rep . 2023 Feb; 96(1):35-40. PMID: 36818325
Background And Aim: Inappropriate use of antibiotics may increase antimicrobial resistance (AMR) among different microorganisms and may lead to treatment failure in neonatal septicemia. The aim of this study was...
10.
Pai V, Subraya C, Holavana Halli Nanjundaiah A, Kamath V, Kunhikatta V
Curr Drug Saf . 2023 Feb; 19(1):19-23. PMID: 36757041
Pharmacovigilance is important for generating accurate safety of herbal medications information. The present methods were designed for synthetic medications and will need to be modified to account for the unique...